All In Biotech

Drug Trial Radar · NCT02236793

A Phase 3 Clinical Trial to Assess the Effectiveness of BioChaperone PDGF-BB In the Treatment of Chronic Diabetic Foot Ulcer

Phase III, Multicentre, Randomized, Parallel Group, Double Blinded and Control Group Clinical Trial to Assess the Effectiveness of BioChaperone PDGF-BB In the Treatment of Chronic Diabetic Foot Ulcer

Last checked: Nov 20, 2026Latest source record: Jun 29, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 252 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

252

Actual

Start

Dec 2014

Primary completion

Aug 2016

Study completion Aug 2016

Sponsor

Lead sponsor
AdociaIndustry
Sponsor type
Industry
Collaborators
Virchow Group
First posted
Sep 11, 2014

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The present clinical trial is designed to assess the effectiveness of BioChaperone PDGF-BB applied at 4 µg/cm² every other day for up to 20 weeks and associated to Standard of Care as compared to Standard of Care alone for the treatment of neuropathic and neurovascular diabetic foot ulcers.(In order to ensure the double-blinding of the treatments, a sterile normal saline solution presented in the same multi-dose spray vials than BioChaperone PDGF-BB will be applied on patients of the control group).

Conditions

  • Diabetic Foot Ulcer

Interventions

  • BioChaperone PDGF-BBDrug

  • Standard of CareOther

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of complete wound closure.Time frame: 20 weeks

Locations

32 sites in 1 country. Site status is shown where the registry gives one.

  • B.J. Medical College and Civil Hospital

    Ahmedabad, India

  • Dr Jivraj Mehta Smarak Health Foundation

    Ahmedabad, India

  • Sangini Hospital

    Ahmedabad, India

  • V.S. General Hospital & Sml NHL Municipal Medical College Sheth

    Ahmedabad, India

  • Rajiv Gandhi Centre for Diabetes and Endocrinology

    Aligarh, India

  • Govt Medical College and Hospital

    Chandigarh, India

  • Sri Ramachandra Medial Centre

    Chennai, India

  • The Madras Diabetes Research Foundation

    Chennai, India

  • The Madras Medical Mission

    Chennai, India

  • Gandhi Medical College & Hospital

    Hyderabad, India

  • Nizam's Institute of Medical Sciences

    Hyderabad, India

  • Sumana Hospital

    Hyderabad, India

  • Surakshaka diabetic Centre(P) Ltd

    Hyderabad, India

  • SMS Medical College & Attached Hospital

    Jaipur, India

  • ILS Hospital

    Kolkata, India

  • IPGME & R and SSKM Hospital

    Kolkata, India

  • Nightingale Hospital

    Kolkata, India

  • Rabindranath Tagore International Insitute of cardiac Sciences

    Kolkata, India

  • Fortis Hospital Phase

    Mohali, India

  • Seth G.S. Medical College and K.E.M Hospital

    Mumbai, India

  • Mysore Medical College & Research Institute

    Mysore, India

  • Govt Medical college & Hospital Medical Square

    Nagpur, India

  • Indira Gandhi Govt Medical College and Hospital

    Nagpur, India

  • B.J. Govt. Medical College and Sassoon Hospital

    Pune, India

  • Inamdar Multispeciality Hospital

    Pune, India

  • Poona Hospital & Research Centre

    Pune, India

  • Shree Giriraj Multispeciality Hospital

    Rajkot, India

  • King Georges Hospital

    Visakhapatnam, India

  • Mediciti Hospital

    Hyderabad, Andhra Pradesh, India

  • SL Raheja Hospital

    Mumbai, Maharashtra, India

  • M.V. Hospital for Diabetes (P) Ltd

    Chennai, Tamil Nadu, India

  • Dr V. Seshiah Diabetes Research Institute, Dr Balaji Diabetes Care centre

    Chennai, Taminadu, India

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.